Adverse eventsMeasurement unclear · overweight or obese adults
1 finding from 1 review
Total and cardiovascular mortality · Adults with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatal or nonfatal myocardial infarction · Adults with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin showed no clear difference in cardiovascular mortality compared with aspirin alone (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin showed no clear difference in all‐cause mortality compared with aspirin alone (low certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to lower fatal and non‐fatal myocardial infarction compared with aspirin alone (moderate certainty).
1 finding from 1 review
Fatal and non‐fatal ischaemic stroke · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to lower fatal and non‐fatal ischaemic stroke compared with aspirin alone (moderate certainty).
1 finding from 1 review
Adverse events · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
1 finding from 1 review
Major bleeding · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to higher major bleeding compared with aspirin alone (moderate certainty).
1 finding from 1 review
Minor bleeding · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to higher minor bleeding compared with aspirin alone (moderate certainty).
1 finding from 1 review
All‐cause mortality · general population including those at moderate to high risk of CVD, mean age between 30 and 75
Systematic screening showed no clear difference in all‐cause mortality compared with no/opportunistic screening (low certainty).
1 finding from 1 review
Stroke · general population including those at moderate to high risk of CVD, mean age between 30 and 75
Systematic screening showed no clear difference in stroke (total) compared with no/opportunistic screening (low certainty).
1 finding from 1 review
Total coronary heart disease · general population including those at moderate to high risk of CVD, mean age between 30 and 75
Systematic screening showed no clear difference in coronary heart disease (total) compared with no/opportunistic screening (low certainty).
1 finding from 1 review
Cholesterol mg/dL · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Systolic blood pressure · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Diastolic blood pressure · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Mortality (all‐cause) · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (all‐cause) compared with any control treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (cardiovascular) compared with any control treatment (moderate certainty).
1 finding from 1 review
Myocardial infarction · any patient population and people with high cardiovascular risk
Colchicine probably leads to lower myocardial Infarction (total) compared with any control treatment (moderate certainty).
1 finding from 1 review
Adverse event (total) · any patient population and people with high cardiovascular risk
It is very uncertain whether colchicine changes adverse event (total) compared with any control treatment (very low certainty).
1 finding from 1 review